GL1X · GenesisL1 explorer

MolNFT v1 · #88535 · protein

Crystal structure of human fto in complex with acylhydrazine inhibitor 21

4CXY · Alpha-ketoglutarate-dependent dioxygenase fto: “Crystal structure of human fto in complex with acylhydrazine inhibitor 21”. X-ray diffraction, 2 ligands (DGR, NI), 5 pockets (best druggability 0.74). MolNFT v1 #88535 on GenesisL1…

PDB
4CXY
Type
protein
Length
436 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-ketoglutarate-dependent dioxygenase fto
EC
1.14.11.-
UniProt
Q9C0B1
Ligands
DGR, NI
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-ketoglutarate-dependent dioxygenase fto (EC 1.14.11.-)protein43639% helix, 20% strandQ9C0B1

Ligands and binding sites

  • DGR · (E)-4-(2-Nicotinoylhydrazinyl)-4-oxobut-2-enoic acid · ligand · chains A
  • NI · Nickel (II) ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11100.740.9420empty
23250.700.8340DGR, NI
3520.400.8218empty
41100.370.7419empty
5570.260.7314empty

Compared structures

  • 4CXY · Crystal structure of human FTO in complex with acylhydrazine inhibitor 21 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9C0B1 · AlphaFold monomer V2.0 prediction for alpha-ketoglutarate-dependent dioxygenase fto… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.